BMO Capital Reiterates Market Perform Rating on Bristol-Myers Squibb Co. (BMY)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 64.19 +2.48 (4.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.71 | 52 Week High | $77.12 | |||
| Open | $63.19 | 52 Week Low | $49.03 | |||
| Day High | $64.24 | P/E | 41.68 | |||
| Day Low | $62.26 | EPS | $1.54 | |||
| Volume | 13,867,634 | |||||
